Indeed, some of the beneficial cardiovascular effects of long-chain omega-3 PUFA and especially EPA, at least those mediated by CYP450/sEH metabolites, could act as compensatory mechanism and thus being more evident in more disadvantageous conditions, that is, obesity together with high blood pressure. The gene discussed is EPHX2; the disease is obesity disorder.